Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2402403
Max Phase: Preclinical
Molecular Formula: C27H25BrN2
Molecular Weight: 377.51
Molecule Type: Small molecule
Associated Items:
ID: ALA2402403
Max Phase: Preclinical
Molecular Formula: C27H25BrN2
Molecular Weight: 377.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: [Br-].c1ccc(CCCn2c3ccccc3c3cc[n+](Cc4ccccc4)cc32)cc1
Standard InChI: InChI=1S/C27H25N2.BrH/c1-3-10-22(11-4-1)14-9-18-29-26-16-8-7-15-24(26)25-17-19-28(21-27(25)29)20-23-12-5-2-6-13-23;/h1-8,10-13,15-17,19,21H,9,14,18,20H2;1H/q+1;/p-1
Standard InChI Key: ZFACVPNTUMNVHK-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 377.51 | Molecular Weight (Monoisotopic): 377.2012 | AlogP: 5.76 | #Rotatable Bonds: 6 |
Polar Surface Area: 8.81 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.34 | CX LogD: 2.34 |
Aromatic Rings: 5 | Heavy Atoms: 29 | QED Weighted: 0.33 | Np Likeness Score: -0.38 |
1. Zhang G, Cao R, Guo L, Ma Q, Fan W, Chen X, Li J, Shao G, Qiu L, Ren Z.. (2013) Synthesis and structure--activity relationships of N²-alkylated quaternary β-carbolines as novel antitumor agents., 65 [PMID:23688697] [10.1016/j.ejmech.2013.04.031] |
Source(1):